Building Value From Various Perspectives – Strategy, Product Adoption & Sales Growth & IP Protection

Recent Posts

• bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening April 9, 2024
• bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results April 1, 2024
• bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement March 8, 2024
• bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement March 6, 2024
• bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung March 5, 2024